Skip to content
← Full study record

NCT02916771 · MORE INFO

Limitations, agreements, and source contact

Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma · Source last updated 2025-08-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
Irene_Ghobrial@DFCI.Harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-4198
title
Dr. Irene Ghobrial
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
Irene_Ghobrial@DFCI.Harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-4198
title
Dr. Irene Ghobrial

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice